Contact Us Today!

617-523-7900

or Use Our Simple Online Form to Give Us Feedback

We welcome your comments and feedback. Please include contact information if you'd like a response.

Did you find this page helpful?





If you would like a response, please include your contact information.

<< Return to Search Results

Demetrios Vavvas, M.D., Ph.D.

Co-Director Ocular Regenerative Medical Institute
Specialties: Retina
Macular Degeneration Unit
Phone Number: 617-573-6874
Fax: 617-573-3698
Location: Mass. Eye and Ear
243 Charles Street
Boston, MA 02114
Office Hours: Tuesdays and Wednesdays, 1:00 p.m. - 5:00 p.m.
Phone Number: 508-378-2058
Location: Mass. Eye and Ear, East Bridgewater
400 North Bedford Street
East Bridgewater, MA 02333
Office Hours: Please call the East Bridgewater office.
Board Certification: Ophthalmology
Graduate School Boston University School of Medicine, Dept. of Physiology
Medical School Boston University School of Medicine
Residency Ophthalmology, Harvard Medical School Department of Ophthalmology Residency Training Program
Fellowship Vitreoretinal Surgery, Mass. Eye and Ear
Teaching Affiliation Associate Professor of Ophthalmology, Harvard Medical School
Biographical Profile:

Demetrios Vavvas, M.D., Ph.D., is a full-time clinician scientist in the Retina Service of Mass. Eye and Ear, an Associate Professor of Ophthalmology with Harvard Medical School, a Principal Investigator in the Angiogenesis Laboratory and the Joan W. Miller Scholar in Retina.

Clinical Interests

AMD (macular degeneration), diabetic retinopathy, oncology

Research Interests

Neuroprotection, melanoma, angiogenesis, retinopathy of prematurity (ROP), diabetes

Publications

For a full publication list, please see his CV or click here for www.pubmed.gov. 

Roh MI, Murakami Y, Thanos A, Vavvas DG, Miller JW. Edaravone, an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment. Invest Ophthalmol Vis Sci. 2011 May; 52(6): 3825-31.

Morizane Y, Thanos A, Takeuchi K, Murakami Y, Kayama M, Trichonas G, Miller J, Foretz M, Viollet B, Vavvas DG. AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts. J Biol Chem. 2011 May 6; 286(18): 16030-8.

Murakami Y, Miller JW, Vavvas DG. RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death. Oncotarget. 2011 Jun; 2(6): 497-509.

Suzuki J, Manola A, Murakami Y, Morizane Y, Takeuchi K, Kayama M, Miller JW, Sobrin L, Vavvas DG. Inhibitory effect of aminoimidazole carboxamide ribonucleotide (AICAR) on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2011 Aug; 52(9): 6565-71.

Chen L, Miller JW, Vavvas D, Kim IK. Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration. Retina.2011 Nov; 31(10): 2078-83.